Creo Medical Group PLC (LON:CREO) Insider Charles Spicer Buys 24,509 Shares

Creo Medical Group PLC (LON:CREO) insider Charles Spicer purchased 24,509 shares of the business’s stock in a transaction on Friday, July 24th. The shares were acquired at an average price of GBX 204 ($2.51) per share, for a total transaction of £49,998.36 ($61,528.87).

Shares of LON:CREO opened at GBX 199 ($2.45) on Thursday. The company has a debt-to-equity ratio of 0.87, a current ratio of 17.03 and a quick ratio of 16.88. The firm has a market capitalization of $313.47 million and a PE ratio of -15.19. The firm’s 50-day moving average is GBX 203.86 and its two-hundred day moving average is GBX 162.40. Creo Medical Group PLC has a 1 year low of GBX 1.97 ($0.02) and a 1 year high of GBX 243 ($2.99).

Creo Medical Group Company Profile

Creo Medical Limited develops and sells instruments for surgical endoscopy in the United Kingdom. The company is developing instruments for endoscopy through a combination of bipolar radiofrequency and microwave energy in a single platform for tissue dissection, resection, ablation, and coagulation. It offers Speedboat RS2 instrument for endoscopic submucosal dissection.

Read More: Earnings Per Share

Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.